The Smart Magazine About Medical Technology Innovations

#30- Innovative Labs

Joint Effort to Aid Diabetes Patients


A recently-announced partnership between two US firms is designed to further artificial pancreas research. Maryland-based Senseonics is developing a subcutaneous continuous glucose monitor (CGM) the size of a pill, part of its Eversense System. It automatically transmits readings to a mobile app for up to 90 days.
The agreement aims to integrate monitor data with the inControl diabetes management software from TypeZero Technologies, located in neighboring Virginia. The readings will enable TypeZero’s artificial pancreas algorithms to control a user’s insulin pump. The combination also can indicate dosage for insulin pen users. Other advantages include the sensor’s small size and life expectancy, far longer than the five to seven days of existing systems.
TypeZero CEO Chad Rogers explains in a press release that “integrating our inControl platform with the reliable and durable Eversense CGM System…could give patients yet another tool for managing their health and simplifying their lives.”

About the Author

Michael Halpern is a US-born and bred writer with experience in radio. He has lived in southern France for 15 years. Michael is the copy editor of MedicalExpo e-magazine.

Related Posts

British firm Dulas snared the 2017 i-Novo Eco Award for its Solar Socket. The device turns the...

The 2017 i-Novo Design Award went to the Derungs OPTICLUX magnifying light. In addition to its...

An innovative hospital bed from JMS won the i-Novo Tech Award for 2017. The Portuguese firm worked...

Style Switcher

Highlight Color:




You can also set your own colors or background from the Admin Panel.